Open AccessImpact of the COVID-19 pandemic on the management of patients with end-stage renal disease
Author(s) -
Szu Yuan Li,
Yu Shuo Tang,
Yu Jiun Chan,
Der Cherng Tarng
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000356
Subject(s) - medicine , end stage renal disease , pandemic , disease , intensive care medicine , isolation (microbiology) , quarantine , hemodialysis , dialysis , covid-19 , nephrology , transmission (telecommunications) , hygiene , infectious disease (medical specialty) , pathology , bioinformatics , electrical engineering , biology , engineering
A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic.